The research area molecular infection medicine is one of the internationally well-recognized research areas at Umeå University.
The multidisciplinary Umeå Centre for Microbial Research (UCMR) has support from Swedish Research Council Research Council (VR) for a Linnaeus Centre with a program that combines chemical biology with internationally-recognized, cutting-edge molecular microbial genetics to identify small molecules that interfere with the virulence of microorganisms (bacteria, viruses, and parasites). UCMR is also host for MIMS (The Laboratory for Molecular Infection Medicine Sweden), the Swedish node of the Nordic EMBL Partnership for Molecular Medicine.
The Umeå University campus is a vibrant, collaborative and multi-disciplinary environment with excellent infrastructure, all within close proximity
Nelson Gekara is a leading young researcher focusing on the regulatory mechanisms of the immune system, specifically how innate immune detections of, and responsiveness to, microbes are mediated by so-called 'pattern recognition receptors'. For an example of infection biology research at Umeå University, read more about his research here and below.
“The university is the place to be for young researchers seeking to set up their independent research within biomedical fields”, says Nelson Gekara.
One of Umeå University’s leading young researchers is Nelson Gekara, who was recruited as a group leader to MIMS (Molecular Infection Medicine Sweden), the Swedish node in the Nordic EMBL partnership for Molecular Medicine.
In his research, Gekara focuses on the regulatory mechanisms of the immune system and is specifically interested in how innate immune detections of and responsiveness to microbes is mediated by so-called pattern recognition receptors (PRRs). These receptors include Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs) and Cytoplasmic DNA sensors (CDRs). Although critical for anti-microbial defenses and subsequent healing, excessive or deregulated activation of PRRs in immune system responses often results in inflammatory diseases and may foster cancer development. Nelson Gekara’s research group want to understand the mechanisms that govern the regulation of PRRs pathways and how the breakdown of such mechanisms culminates in diseases, such as sepsis, arthritis and inflammatory bowel diseases and cancer.
http://horizon2020projects.com/publications Issue 10, pages 48-49